{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:35:00Z","timestamp":1778812500306,"version":"3.51.4"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T00:00:00Z","timestamp":1232668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12311-008-0084-2","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T19:11:26Z","timestamp":1232651486000},"page":"245-259","source":"Crossref","is-referenced-by-count":30,"title":["Friedreich\u2019s Ataxia: From the (GAA) n Repeat Mediated Silencing to New Promising Molecules for Therapy"],"prefix":"10.1007","volume":"8","author":[{"given":"Daniele","family":"Marmolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Acquaviva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,23]]},"reference":[{"issue":"1","key":"84_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.37.1.1","volume":"37","author":"M Delatycki","year":"2000","unstructured":"Delatycki M, Williamson R, Forrest S (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1\u20138","journal-title":"J Med Genet"},{"issue":"8","key":"84_CR2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.38.8.1292","volume":"38","author":"G Finocchiaro","year":"1988","unstructured":"Finocchiaro G, Baio G, Micossi P, Pozza G, di Donato S (1988) Glucose metabolism alterations in Friedreich\u2019s ataxia. Neurology 38(8):1292\u20131296","journal-title":"Neurology"},{"issue":"6","key":"84_CR3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1531-8257(200011)15:6<1255::AID-MDS1031>3.0.CO;2-C","volume":"15","author":"A Filla","year":"2000","unstructured":"Filla A, De Michele G, Coppola G, Federico A, Vita G, Toscano A et al (2000) Accuracy of clinical diagnostic criteria for Friedreich\u2019s ataxia. Mov Disord 15(6):1255\u20131258","journal-title":"Mov Disord"},{"issue":"3","key":"84_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1071-9091(03)00025-1","volume":"10","author":"M Pandolfo","year":"2003","unstructured":"Pandolfo M (2003) Friedreich ataxia. Semin Pediatr Neurol 10(3):163\u2013172","journal-title":"Semin Pediatr Neurol"},{"issue":"6","key":"84_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00315657","volume":"237","author":"A Filla","year":"1990","unstructured":"Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich\u2019s disease: a study of 80 Italian patients. J Neurol 237(6):345\u2013351","journal-title":"J Neurol"},{"issue":"4","key":"84_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S0317167100025609","volume":"3","author":"D Shapcott","year":"1976","unstructured":"Shapcott D, Melancon S, Butterworth R, Khoury K, Collu R, Breton G et al (1976) Glucose and insulin metabolism in Friedreich\u2019s ataxia. Can J Neurol Sci 3(4):361\u2013364","journal-title":"Can J Neurol Sci"},{"issue":"5254","key":"84_CR7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 M, Pianese L, Coss\u00e9e M, Cavalcanti F et al (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271(5254):1423\u20131427","journal-title":"Science"},{"issue":"11","key":"84_CR8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","volume":"6","author":"V Campuzano","year":"1997","unstructured":"Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S et al (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6(11):1771\u20131780","journal-title":"Hum Mol Genet"},{"issue":"1","key":"84_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s100480050007","volume":"1","author":"M Kostrzewa","year":"1997","unstructured":"Kostrzewa M, Klockgether T, Damian M, M\u00fcller U (1997) Locus heterogeneity in Friedreich ataxia. Neurogenetics 1(1):43\u201347","journal-title":"Neurogenetics"},{"issue":"4","key":"84_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0897-345","volume":"16","author":"H Koutnikova","year":"1997","unstructured":"Koutnikova H, Campuzano V, Foury F, Doll\u00e9 P, Cazzalini O, Koenig M (1997) Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 16(4):345\u2013351","journal-title":"Nat Genet"},{"issue":"5","key":"84_CR11","first-page":"1251","volume":"60","author":"S Bidichandani","year":"1997","unstructured":"Bidichandani S, Ashizawa T, Patel P (1997) Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet 60(5):1251\u20131256","journal-title":"Am J Hum Genet"},{"key":"84_CR12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"H Orr","year":"2007","unstructured":"Orr H, Zoghbi H (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"84_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/jnnp.2003.028605","volume":"75","author":"L Pianese","year":"2004","unstructured":"Pianese L, Turano M, Lo Casale M, De Biase I, Giacchetti M, Monticelli A et al (2004) Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers. J Neurol Neurosurg Psychiatry 75(7):1061\u20131063","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","volume":"96","author":"R Lodi","year":"1999","unstructured":"Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, Schapira AH (1999) Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A 96:11492\u201311495","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"84_CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(94)90346-8","volume":"76","author":"C Askwith","year":"1994","unstructured":"Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, Kaplan J (1994) The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76(2):403\u2013410","journal-title":"Cell"},{"issue":"5255","key":"84_CR16","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.271.5255.1552","volume":"271","author":"R Stearman","year":"1996","unstructured":"Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A (1996) A permease\u2013oxidase complex involved in high-affinity iron uptake in yeast. Science 271(5255):1552\u20131557","journal-title":"Science"},{"key":"84_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-211-45295-0_22","volume":"70","author":"M Pandolfo","year":"2006","unstructured":"Pandolfo M (2006) Iron and Friedreich ataxia. J Neural Transm Suppl 70:143\u2013146","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"84_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025464","volume":"3","author":"G Geoffroy","year":"1976","unstructured":"Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C et al (1976) Clinical description and roentgenologic evaluation of patients with Friedreich\u2019s ataxia. Can J Neurol Sci 3(4):279\u2013286","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"84_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"A Harding","year":"1981","unstructured":"Harding A (1981) Friedreich\u2019s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589\u2013620","journal-title":"Brain"},{"issue":"8","key":"84_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.1993.00540080014006","volume":"50","author":"T Klockgether","year":"1993","unstructured":"Klockgether T, Chamberlain S, W\u00fcllner U, Fetter M, Dittmann H, Petersen D et al (1993) Late-onset Friedreich\u2019s ataxia. Molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Arch Neurol 50(8):803\u2013806","journal-title":"Arch Neurol"},{"issue":"16","key":"84_CR21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A D\u00fcrr","year":"1996","unstructured":"D\u00fcrr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C et al (1996) Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N Engl J Med 335(16):1169\u20131175","journal-title":"N Engl J Med"},{"issue":"Pt 4","key":"84_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/brain\/120.4.673","volume":"120","author":"P Lamont","year":"1997","unstructured":"Lamont P, Davis M, Wood N (1997) Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich\u2019s ataxia in 56 patients. Clinical and genetic correlates. Brain 120(Pt 4):673\u2013680","journal-title":"Brain"},{"issue":"Pt 12","key":"84_CR23","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/120.12.2131","volume":"120","author":"L Sch\u00f6ls","year":"1997","unstructured":"Sch\u00f6ls L, Amoiridis G, Przuntek H, Frank G, Epplen J, Epplen C (1997) Friedreich\u2019s ataxia. Revision of the phenotype according to molecular genetics. Brain 120(Pt 12):2131\u20132140","journal-title":"Brain"},{"issue":"23","key":"84_CR24","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1074\/jbc.273.23.14588","volume":"273","author":"K Ohshima","year":"1998","unstructured":"Ohshima K, Montermini L, Wells R, Pandolfo M (1998) Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J Biol Chem 273(23):14588\u201314595","journal-title":"J Biol Chem"},{"issue":"1","key":"84_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/301680","volume":"62","author":"S Bidichandani","year":"1998","unstructured":"Bidichandani S, Ashizawa T, Patel P (1998) The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 62(1):111\u2013121","journal-title":"Am J Hum Genet"},{"issue":"4","key":"84_CR26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80474-8","volume":"3","author":"N Sakamoto","year":"1999","unstructured":"Sakamoto N, Chastain P, Parniewski P, Ohshima K, Pandolfo M, Griffith J et al (1999) Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich\u2019s ataxia. Mol Cell 3(4):465\u2013475","journal-title":"Mol Cell"},{"issue":"29","key":"84_CR27","doi-asserted-by":"crossref","first-page":"27171","DOI":"10.1074\/jbc.M101879200","volume":"276","author":"N Sakamoto","year":"2001","unstructured":"Sakamoto N, Ohshima K, Montermini L, Pandolfo M, Wells R (2001) Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem 276(29):27171\u201327177","journal-title":"J Biol Chem"},{"issue":"6","key":"84_CR28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.07-097857","volume":"22","author":"R Wells","year":"2008","unstructured":"Wells R (2008) DNA triplexes and Friedreich ataxia. FASEB J 22(6):1625\u20131634","journal-title":"FASEB J"},{"issue":"24","key":"84_CR29","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1093\/nar\/28.24.4930","volume":"28","author":"E Grabczyk","year":"2000","unstructured":"Grabczyk E, Usdin K (2000) Alleviating transcript insufficiency caused by Friedreich\u2019s ataxia triplet repeats. Nucleic Acids Res 28(24):4930\u20134937","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"84_CR30","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1093\/nar\/gkm589","volume":"35","author":"E Grabczyk","year":"2007","unstructured":"Grabczyk E, Mancuso M, Sammarco M (2007) A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res 35(16):5351\u20135359","journal-title":"Nucleic Acids Res"},{"issue":"6934","key":"84_CR31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature01596","volume":"422","author":"A Saveliev","year":"2003","unstructured":"Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R (2003) DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 422(6934):909\u2013913","journal-title":"Nature"},{"issue":"3\u20134","key":"84_CR32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0361-9230(01)00572-X","volume":"56","author":"E Grabczyk","year":"2001","unstructured":"Grabczyk E, Kumari D, Usdin K (2001) Fragile X syndrome and Friedreich\u2019s ataxia: two different paradigms for repeat induced transcript insufficiency. Brain Res Bull 56(3\u20134):367\u2013373","journal-title":"Brain Res Bull"},{"issue":"7","key":"84_CR33","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/MCB.25.7.2525-2538.2005","volume":"25","author":"M Stewart","year":"2005","unstructured":"Stewart M, Li J, Wong J (2005) Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol 25(7):2525\u20132538","journal-title":"Mol Cell Biol"},{"issue":"9","key":"84_CR34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","volume":"14","author":"L Kernochan","year":"2005","unstructured":"Kernochan L, Russo M, Woodling N, Huynh T, Avila A, Fischbeck K et al (2005) The role of histone acetylation in SMN gene expression. Hum Mol Genet 14(9):1171\u20131182","journal-title":"Hum Mol Genet"},{"issue":"1","key":"84_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1568007053005091","volume":"4","author":"B Langley","year":"2005","unstructured":"Langley B, Gensert J, Beal M, Ratan R (2005) Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4(1):41\u201350","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"3","key":"84_CR36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2005.09.002","volume":"20","author":"D Cho","year":"2005","unstructured":"Cho D, Thienes C, Mahoney S, Analau E, Filippova G, Tapscott S (2005) Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 20(3):483\u2013489","journal-title":"Mol Cell"},{"issue":"2","key":"84_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0959-437X(98)80148-2","volume":"8","author":"S Tapscott","year":"1998","unstructured":"Tapscott S, Klesert T, Widrow R, St\u00f6ger R, Laird C (1998) Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes. Curr Opin Genet Dev 8(2):245\u2013253","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"84_CR38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","volume":"2","author":"D Herman","year":"2006","unstructured":"Herman D, Jenssen K, Burnett R, Soragni E, Perlman S, Gottesfeld J (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich\u2019s ataxia. Nat Chem Biol 2(10):551\u2013558","journal-title":"Nat Chem Biol"},{"issue":"2","key":"84_CR39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pharmthera.2007.06.014","volume":"116","author":"J Gottesfeld","year":"2007","unstructured":"Gottesfeld J (2007) Small molecules affecting transcription in Friedreich ataxia. Pharmacol Ther 116(2):236\u2013248","journal-title":"Pharmacol Ther"},{"issue":"23","key":"84_CR40","doi-asserted-by":"crossref","first-page":"R895","DOI":"10.1016\/j.cub.2003.11.006","volume":"13","author":"S Elgin","year":"2003","unstructured":"Elgin S, Grewal S (2003) Heterochromatin: silence is golden. Curr Biol 13(23):R895\u2013R898","journal-title":"Curr Biol"},{"issue":"1\u20133","key":"84_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","volume":"512","author":"C Miranda","year":"2002","unstructured":"Miranda C, Santos M, Ohshima K, Smith J, Li L, Bunting M et al (2002) Frataxin knockin mouse. FEBS Lett 512(1\u20133):291\u2013297","journal-title":"FEBS Lett"},{"issue":"4","key":"84_CR42","doi-asserted-by":"crossref","first-page":"e1958","DOI":"10.1371\/journal.pone.0001958","volume":"3","author":"M Rai","year":"2008","unstructured":"Rai M, Soragni E, Jenssen K, Burnett R, Herman D, Coppola G et al (2008) HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE 3(4):e1958","journal-title":"PLoS ONE"},{"issue":"10","key":"84_CR43","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/nar\/gkm271","volume":"35","author":"E Greene","year":"2007","unstructured":"Greene E, Mahishi L, Entezam A, Kumari D, Usdin K (2007) Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res 35(10):3383\u20133390","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"84_CR44","first-page":"63","volume":"9","author":"A El-Osta","year":"2000","unstructured":"El-Osta A, Wolffe A (2000) DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr 9(1\u20132):63\u201375","journal-title":"Gene Expr"},{"key":"84_CR45","doi-asserted-by":"crossref","unstructured":"Castaldo I, Pinelli M, Monticelli A, Acquaviva F, Giacchetti M, Filla A et al (2008) DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich\u2019s ataxia patients. J Med Genet 45:808\u2013812","DOI":"10.1136\/jmg.2008.058594"},{"issue":"5","key":"84_CR46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/ddm346","volume":"17","author":"S Al-Mahdawi","year":"2008","unstructured":"Al-Mahdawi S, Pinto R, Ismail O, Varshney D, Lymperi S, Sandi C et al (2008) The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 17(5):735\u2013746","journal-title":"Hum Mol Genet"},{"issue":"5319","key":"84_CR47","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","volume":"276","author":"M Babcock","year":"1997","unstructured":"Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276(5319):1709\u20131712","journal-title":"Science"},{"issue":"2\u20133","key":"84_CR48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-5793(97)00734-5","volume":"411","author":"F Foury","year":"1997","unstructured":"Foury F, Cazzalini O (1997) Deletion of the yeast homologue of the human gene associated with Friedreich\u2019s ataxia elicits iron accumulation in mitochondria. FEBS Lett 411(2\u20133):373\u2013377","journal-title":"FEBS Lett"},{"issue":"24","key":"84_CR49","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/hmg\/ddi393","volume":"14","author":"R Schoenfeld","year":"2005","unstructured":"Schoenfeld R, Napoli E, Wong A, Zhan S, Reutenauer L, Morin D et al (2005) Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum Mol Genet 14(24):3787\u20133799","journal-title":"Hum Mol Genet"},{"issue":"23","key":"84_CR50","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1093\/hmg\/ddh324","volume":"3","author":"O Stehling","year":"2004","unstructured":"Stehling O, Els\u00e4sser H, Br\u00fcckel B, M\u00fchlenhoff U, Lill R (2004) Iron\u2013sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 3(23):3007\u20133015","journal-title":"Hum Mol Genet"},{"issue":"1\u20133","key":"84_CR51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-5793(03)01498-4","volume":"557","author":"A Ramazzotti","year":"2004","unstructured":"Ramazzotti A, Vanmansart V, Foury F (2004) Mitochondrial functional interactions between frataxin and Isu1p, the iron\u2013sulfur cluster scaffold protein, in Saccharomyces cerevisiae. FEBS Lett 557(1\u20133):215\u2013220","journal-title":"FEBS Lett"},{"issue":"20","key":"84_CR52","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1021\/ja027967i","volume":"125","author":"T Yoon","year":"2003","unstructured":"Yoon T, Cowan J (2003) Iron\u2013sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe\u20132S] clusters in ISU-type proteins. J Am Chem Soc 125(20):6078\u20136084","journal-title":"J Am Chem Soc"},{"issue":"25","key":"84_CR53","doi-asserted-by":"crossref","first-page":"25943","DOI":"10.1074\/jbc.C400107200","volume":"279","author":"T Yoon","year":"2004","unstructured":"Yoon T, Cowan J (2004) Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem 279(25):25943\u201325946","journal-title":"J Biol Chem"},{"issue":"20","key":"84_CR54","doi-asserted-by":"crossref","first-page":"19794","DOI":"10.1074\/jbc.M500397200","volume":"280","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Lyver E, Knight S, Lesuisse E, Dancis A (2005) Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J Biol Chem 280(20):19794\u201319807","journal-title":"J Biol Chem"},{"issue":"18","key":"84_CR55","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1093\/emboj\/cdg446","volume":"22","author":"U M\u00fchlenhoff","year":"2003","unstructured":"M\u00fchlenhoff U, Gerber J, Richhardt N, Lill R (2003) Components involved in assembly and dislocation of iron\u2013sulfur clusters on the scaffold protein Isu1p. EMBO J 22(18):4815\u20134825","journal-title":"EMBO J"},{"issue":"33","key":"84_CR56","doi-asserted-by":"crossref","first-page":"31340","DOI":"10.1074\/jbc.M303158200","volume":"278","author":"S Park","year":"2003","unstructured":"Park S, Gakh O, O\u2019Neill H, Mangravita A, Nichol H, Ferreira G et al (2003) Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J Biol Chem 278(33):31340\u201331351","journal-title":"J Biol Chem"},{"issue":"21","key":"84_CR57","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1021\/bi025566+","volume":"41","author":"O Gakh","year":"2002","unstructured":"Gakh O, Adamec J, Gacy A, Twesten R, Owen W, Isaya G (2002) Physical evidence that yeast frataxin is an iron storage protein. Biochemistry 41(21):6798\u20136804","journal-title":"Biochemistry"},{"issue":"3","key":"84_CR58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/hmg\/ddi461","volume":"15","author":"O Gakh","year":"2006","unstructured":"Gakh O, Park S, Liu G, Macomber L, Imlay J, Ferreira G et al (2006) Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet 15(3):467\u2013479","journal-title":"Hum Mol Genet"},{"issue":"2","key":"84_CR59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/bi048459j","volume":"44","author":"H O\u2019Neill","year":"2005","unstructured":"O\u2019Neill H, Gakh O, Park S, Cui J, Mooney S, Sampson M et al (2005) Assembly of human frataxin is a mechanism for detoxifying redox-active iron. Biochemistry 44(2):537\u2013545","journal-title":"Biochemistry"},{"issue":"10","key":"84_CR60","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.str.2006.08.010","volume":"14","author":"T Karlberg","year":"2006","unstructured":"Karlberg T, Schagerl\u00f6f U, Gakh O, Park S, Ryde U, Lindahl M et al (2006) The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. Structure 14(10):1535\u20131546","journal-title":"Structure"},{"issue":"3","key":"84_CR61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/303056","volume":"67","author":"J Adamec","year":"2000","unstructured":"Adamec J, Rusnak F, Owen W, Naylor S, Benson L, Gacy A et al (2000) Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet 67(3):549\u2013562","journal-title":"Am J Hum Genet"},{"issue":"19","key":"84_CR62","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/10.19.2061","volume":"10","author":"K Chantrel-Groussard","year":"2001","unstructured":"Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, R\u00f6tig A et al (2001) Disabled early recruitment of antioxidant defenses in Friedreich\u2019s ataxia. Hum Mol Genet 10(19):2061\u20132067","journal-title":"Hum Mol Genet"},{"issue":"11","key":"84_CR63","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/hmg\/11.11.1351","volume":"11","author":"G Karthikeyan","year":"2002","unstructured":"Karthikeyan G, Lewis L, Resnick M (2002) The mitochondrial protein frataxin prevents nuclear damage. Hum Mol Genet 11(11):1351\u20131362","journal-title":"Hum Mol Genet"},{"issue":"24","key":"84_CR64","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/hmg\/ddg349","volume":"12","author":"G Karthikeyan","year":"2003","unstructured":"Karthikeyan G, Santos J, Graziewicz M, Copeland W, Isaya G, Van Houten B et al (2003) Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet 12(24):3331\u20133342","journal-title":"Hum Mol Genet"},{"issue":"3","key":"84_CR65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/hmg\/8.3.425","volume":"8","author":"A Wong","year":"1999","unstructured":"Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F et al (1999) The Friedreich\u2019s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 8(3):425\u2013430","journal-title":"Hum Mol Genet"},{"issue":"52","key":"84_CR66","doi-asserted-by":"crossref","first-page":"41469","DOI":"10.1074\/jbc.M006539200","volume":"275","author":"P Cavadini","year":"2000","unstructured":"Cavadini P, Adamec J, Taroni F, Gakh O, Isaya G (2000) Two-step processing of human frataxin by mitochondrial processing peptidase. Precursor and intermediate forms are cleaved at different rates. J Biol Chem 275(52):41469\u201341475","journal-title":"J Biol Chem"},{"issue":"4","key":"84_CR67","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00775-007-0205-2","volume":"12","author":"T Yoon","year":"2007","unstructured":"Yoon T, Dizin E, Cowan J (2007) N-terminal iron-mediated self-cleavage of human frataxin: regulation of iron binding and complex formation with target proteins. J Biol Inorg Chem 12(4):535\u2013542","journal-title":"J Biol Inorg Chem"},{"issue":"13","key":"84_CR68","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/hmg\/ddm102","volume":"16","author":"I Cond\u00f2","year":"2007","unstructured":"Cond\u00f2 I, Ventura N, Malisan F, Rufini A, Tomassini B, Testi R (2007) In vivo maturation of human frataxin. Hum Mol Genet 16(13):1534\u20131540","journal-title":"Hum Mol Genet"},{"issue":"15","key":"84_CR69","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0610618104","volume":"104","author":"N Babady","year":"2007","unstructured":"Babady N, Pang Y, Elpeleg O, Isaya G (2007) Cryptic proteolytic activity of dihydrolipoamide dehydrogenase. Proc Natl Acad Sci U S A 104(15):6158\u20136163","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 17","key":"84_CR70","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1242\/jcs.02516","volume":"118","author":"F Acquaviva","year":"2005","unstructured":"Acquaviva F, De Biase I, Nezi L, Ruggiero G, Tatangelo F, Pisano C et al (2005) Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2. J Cell Sci 118(Pt 17):3917\u20133924","journal-title":"J Cell Sci"},{"issue":"24","key":"84_CR71","doi-asserted-by":"crossref","first-page":"16750","DOI":"10.1074\/jbc.M511960200","volume":"281","author":"I Cond\u00f2","year":"2006","unstructured":"Cond\u00f2 I, Ventura N, Malisan F, Tomassini B, Testi R (2006) A pool of extramitochondrial frataxin that promotes cell survival. J Biol Chem 281(24):16750\u201316756","journal-title":"J Biol Chem"},{"issue":"3","key":"84_CR72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jmb.2004.10.074","volume":"345","author":"H O\u2019Neill","year":"2005","unstructured":"O\u2019Neill H, Gakh O, Isaya G (2005) Supramolecular assemblies of human frataxin are formed via subunit\u2013subunit interactions mediated by a non-conserved amino-terminal region. J Mol Biol 345(3):433\u2013439","journal-title":"J Mol Biol"},{"issue":"3\u20134","key":"84_CR73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/ars.2006.8.506","volume":"8","author":"E Napoli","year":"2006","unstructured":"Napoli E, Taroni F, Cortopassi G (2006) Frataxin, iron\u2013sulfur clusters, heme, ROS, and aging. Antioxid Redox Signal 8(3\u20134):506\u2013516","journal-title":"Antioxid Redox Signal"},{"issue":"15","key":"84_CR74","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddi214","volume":"14","author":"P Gonz\u00e1lez-Cabo","year":"2005","unstructured":"Gonz\u00e1lez-Cabo P, V\u00e1zquez-Manrique R, Garc\u00eda-Gimeno M, Sanz P, Palau F (2005) Frataxin interacts functionally with mitochondrial electron transport chain proteins. Hum Mol Genet 14(15):2091\u20132098","journal-title":"Hum Mol Genet"},{"issue":"2\u20135","key":"84_CR75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0960-0760(03)00214-0","volume":"85","author":"C Blanquart","year":"2003","unstructured":"Blanquart C, Barbier O, Fruchart J, Staels B, Glineur C (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85(2\u20135):267\u2013273","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6634","key":"84_CR76","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/42652","volume":"387","author":"J Torchia","year":"1997","unstructured":"Torchia J, Rose D, Inostroza J, Kamei Y, Westin S, Glass C et al (1997) The transcriptional co-activator p\/CIP binds CBP and mediates nuclear-receptor function. Nature 387(6634):677\u2013684. Jun","journal-title":"Nature"},{"issue":"4","key":"84_CR77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/gad.1177604","volume":"18","author":"D Kelly","year":"2004","unstructured":"Kelly D, Scarpulla R (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18(4):357\u2013368","journal-title":"Genes Dev"},{"issue":"1","key":"84_CR78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98(1):115\u2013124","journal-title":"Cell"},{"issue":"2","key":"84_CR79","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre J, Drori S, Uldry M, Silvaggi J, Rhee J, J\u00e4ger S et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2):397\u2013408","journal-title":"Cell"},{"key":"84_CR80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstr\u00e5le M, Laurila E et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273","journal-title":"Nat Genet"},{"key":"84_CR81","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"ME Patti","year":"2003","unstructured":"Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466\u20138471","journal-title":"Proc Natl Acad Sci U S A"},{"key":"84_CR82","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00125-006-0268-6","volume":"49","author":"S Soyal","year":"2006","unstructured":"Soyal S, Krempler F, Oberkofler H, Patsch W (2006) PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49:1477\u20131488","journal-title":"Diabetologia"},{"key":"84_CR83","first-page":"766","volume-title":"Genetic instabilities and neurological diseases","author":"RB Wilson","year":"2006","unstructured":"Wilson RB (2006) Experimental therapeutics for Friedreich ataxia. In: Wells RD, Warren ST, Sarmiento M (eds) Genetic instabilities and neurological diseases, 2nd edn. Academic, San Diego, p 766","edition":"2"},{"issue":"12","key":"84_CR84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1248\/bpb1978.8.1006","volume":"8","author":"Y Sugiyama","year":"1985","unstructured":"Sugiyama Y, Fujita T, Matsumoto M, Okamoto K, Imada I (1985) Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs. J Pharmacobiodyn 8(12):1006\u20131017","journal-title":"J Pharmacobiodyn"},{"issue":"9177","key":"84_CR85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","volume":"354","author":"P Rustin","year":"1999","unstructured":"Rustin P, von Kleist-Retzow J, Chantrel-Groussard K, Sidi D, Munnich A, R\u00f6tig A (1999) Effect of idebenone on cardiomyopathy in Friedreich\u2019s ataxia: a preliminary study. Lancet 354(9177):477\u2013479","journal-title":"Lancet"},{"issue":"10","key":"84_CR86","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","volume":"6","author":"N Prospero Di","year":"2007","unstructured":"Di Prospero N, Baker A, Jeffries N, Fischbeck K (2007) Neurological effects of high-dose idebenone in patients with Friedreich\u2019s ataxia: a randomised, placebo-controlled trial. Lancet Neurol 6(10):878\u2013886","journal-title":"Lancet Neurol"},{"issue":"9004","key":"84_CR87","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(96)90866-1","volume":"347","author":"N Stephens","year":"1996","unstructured":"Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson M (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347(9004):781\u2013786","journal-title":"Lancet"},{"issue":"3 Suppl 1","key":"84_CR88","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1002\/ana.410440724","volume":"44","author":"I Shoulson","year":"1998","unstructured":"Shoulson I (1998) DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl and tocopherol antioxidative therapy of Parkinsonism. Ann Neurol 44(3 Suppl 1):S160\u2013S166","journal-title":"Ann Neurol"},{"issue":"18","key":"84_CR89","first-page":"4230","volume":"53","author":"R Bostick","year":"1993","unstructured":"Bostick R, Potter J, McKenzie D, Sellers T, Kushi L, Steinmetz K et al (1993) Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women\u2019s Health Study. Cancer Res 53(18):4230\u20134237","journal-title":"Cancer Res"},{"issue":"7","key":"84_CR90","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.56.7.849","volume":"56","author":"O Musumeci","year":"2001","unstructured":"Musumeci O, Naini A, Slonim A, Skavin N, Hadjigeorgiou G, Krawiecki N et al (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56(7):849\u2013855","journal-title":"Neurology"},{"issue":"Suppl","key":"84_CR91","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.mito.2007.04.001","volume":"7","author":"J Cooper","year":"2007","unstructured":"Cooper J, Schapira A (2007) Friedreich\u2019s ataxia: coenzyme Q10 and vitamin E therapy. Mitochondrion 7(Suppl):S127\u2013S135","journal-title":"Mitochondrion"},{"issue":"4","key":"84_CR92","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archneur.62.4.621","volume":"62","author":"P Hart","year":"2005","unstructured":"Hart P, Lodi R, Rajagopalan B, Bradley J, Crilley J, Turner C et al (2005) Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 62(4):621\u2013626","journal-title":"Arch Neurol"},{"issue":"4","key":"84_CR93","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/heart.87.4.346","volume":"87","author":"A Hausse","year":"2002","unstructured":"Hausse A, Aggoun Y, Bonnet D, Sidi D, Munnich A, R\u00f6tig A et al (2002) Idebenone and reduced cardiac hypertrophy in Friedreich\u2019s ataxia. Heart 87(4):346\u2013349","journal-title":"Heart"},{"issue":"10","key":"84_CR94","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.WNL.0000068549.52812.0F","volume":"60","author":"G Buyse","year":"2003","unstructured":"Buyse G, Mertens L, Di Salvo G, Matthijs I, Weidemann F, Eyskens B et al (2003) Idebenone treatment in Friedreich\u2019s ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60(10):1679\u20131681","journal-title":"Neurology"},{"issue":"6","key":"84_CR95","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpn.2007.11.006","volume":"12","author":"M Pineda","year":"2008","unstructured":"Pineda M, Arpa J, Montero R, Aracil A, Dom\u00ednguez F, Galv\u00e1n M et al (2008) Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Eur J Paediatr Neurol 12(6):470\u2013475","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"84_CR96","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","volume":"276","author":"G Kelso","year":"2001","unstructured":"Kelso G, Porteous C, Coulter C, Hughes G, Porteous W, Ledgerwood E et al (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276(7):4588\u20134596","journal-title":"J Biol Chem"},{"issue":"9","key":"84_CR97","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","volume":"100","author":"R Smith","year":"2003","unstructured":"Smith R, Porteous C, Gane A, Murphy M (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A 100(9):5407\u20135412","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"84_CR98","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","volume":"57","author":"D Kalinowski","year":"2005","unstructured":"Kalinowski D, Richardson D (2005) The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev 57(4):547\u2013583","journal-title":"Pharmacol Rev"},{"issue":"2\u20133","key":"84_CR99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4439(01)00041-2","volume":"1536","author":"D Richardson","year":"2001","unstructured":"Richardson D, Mouralian C, Ponka P, Becker E (2001) Development of potential iron chelators for the treatment of Friedreich\u2019s ataxia: ligands that mobilize mitochondrial iron. Biochim Biophys Acta 1536(2\u20133):133\u2013140","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"84_CR100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H","volume":"46","author":"D Waldvogel","year":"1999","unstructured":"Waldvogel D, van Gelderen P, Hallett M (1999) Increased iron in the dentate nucleus of patients with Friedrich\u2019s ataxia. Ann Neurol 46(1):123\u2013125","journal-title":"Ann Neurol"},{"issue":"3","key":"84_CR101","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.spen.2006.08.005","volume":"13","author":"R Wilson","year":"2006","unstructured":"Wilson R (2006) Iron dysregulation in Friedreich ataxia. Semin Pediatr Neurol 13(3):166\u2013175","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"84_CR102","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/13543784.12.2.235","volume":"12","author":"D Richardson","year":"2003","unstructured":"Richardson D (2003) Friedreich\u2019s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy? Expert Opin Investig Drugs 12(2):235\u2013245","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"84_CR103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","volume":"110","author":"N Boddaert","year":"2007","unstructured":"Boddaert N, Le Quan Sang K, R\u00f6tig A, Leroy-Willig A, Gallet S, Brunelle F et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110(1):401\u2013408","journal-title":"Blood"},{"issue":"3","key":"84_CR104","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood-2007-07-102335","volume":"111","author":"Y Sohn","year":"2008","unstructured":"Sohn Y, Breuer W, Munnich A, Cabantchik Z (2008) Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111(3):1690\u20131699","journal-title":"Blood"},{"issue":"15","key":"84_CR105","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","volume":"17","author":"K Li","year":"2008","unstructured":"Li K, Besse E, Ha D, Kovtunovych G, Rouault T (2008) Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum Mol Genet 17(15):2265\u20132273","journal-title":"Hum Mol Genet"},{"key":"84_CR106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2377-8-20","volume":"8","author":"S Goncalves","year":"2008","unstructured":"Goncalves S, Paupe V, Dassa E, Rustin P (2008) Deferiprone targets aconitase: implication for Friedreich\u2019s ataxia treatment. BMC Neurol 8:20","journal-title":"BMC Neurol"},{"key":"84_CR107","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","volume":"45","author":"D Drummond","year":"2005","unstructured":"Drummond D, Noble C, Kirpotin D, Guo Z, Scott G, Benz C (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45:495\u2013528","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"84_CR108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrg1690","volume":"6","author":"N Prospero Di","year":"2005","unstructured":"Di Prospero N, Fischbeck K (2005) Therapeutics development for triplet repeat expansion diseases. Nat Rev Genet 6(10):756\u2013765","journal-title":"Nat Rev Genet"},{"issue":"1","key":"84_CR109","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","volume":"120","author":"M Riessland","year":"2006","unstructured":"Riessland M, Brichta L, Hahnen E, Wirth B (2006) The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells. Hum Genet 120(1):101\u2013110","journal-title":"Hum Genet"},{"issue":"1","key":"84_CR110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jgm.320","volume":"5","author":"J Sarsero","year":"2003","unstructured":"Sarsero J, Li L, Wardan H, Sitte K, Williamson R, Ioannou P (2003) Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia. J Gene Med 5(1):72\u201381","journal-title":"J Gene Med"},{"issue":"1","key":"84_CR111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","volume":"76","author":"E Morishita","year":"1997","unstructured":"Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76(1):105\u2013116","journal-title":"Neuroscience"},{"issue":"19","key":"84_CR112","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"M Brines","year":"2000","unstructured":"Brines M, Ghezzi P, Keenan S, Agnello D, de Lanerolle N, Cerami C et al (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97(19):10526\u201310531","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"84_CR113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00228-005-0896-7","volume":"61","author":"A Xenocostas","year":"2005","unstructured":"Xenocostas A, Cheung W, Farrell F, Zakszewski C, Kelley M, Lutynski A et al (2005) The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61(3):189\u2013195","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"84_CR114","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","volume":"95","author":"M Sakanaka","year":"1998","unstructured":"Sakanaka M, Wen T, Matsuda S, Masuda S, Morishita E, Nagao M et al (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95(8):4635\u20134640","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"84_CR115","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","volume":"98","author":"A Sir\u00e9n","year":"2001","unstructured":"Sir\u00e9n A, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P et al (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98(7):4044\u20134049","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"84_CR116","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2004.03.017","volume":"63","author":"M Bogoyevitch","year":"2004","unstructured":"Bogoyevitch M (2004) An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 63(2):208\u2013216","journal-title":"Cardiovasc Res"},{"issue":"11","key":"84_CR117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2362.2005.01568.x","volume":"35","author":"B Sturm","year":"2005","unstructured":"Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J et al (2005) Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest 35(11):711\u2013717","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"84_CR118","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12311-008-0036-x","volume":"7","author":"F Acquaviva","year":"2008","unstructured":"Acquaviva F, Castaldo I, Filla A, Giacchetti M, Marmolino D, Monticelli A et al (2008) Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression. Cerebellum 7(3):360\u2013365","journal-title":"Cerebellum"},{"issue":"5","key":"84_CR119","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21177","volume":"62","author":"S Boesch","year":"2007","unstructured":"Boesch S, Sturm B, Hering S, Goldenberg H, Poewe W, Scheiber-Mojdehkar B (2007) Friedreich\u2019s ataxia: clinical pilot trial with recombinant human erythropoietin. Ann Neurol 62(5):521\u2013524","journal-title":"Ann Neurol"},{"key":"84_CR120","doi-asserted-by":"crossref","unstructured":"Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim S (2006) Pioglitazone for type 2 diabetes mellitus. Cochrane Database Syst Rev (4):CD006060","DOI":"10.1002\/14651858.CD006060.pub2"},{"key":"84_CR121","doi-asserted-by":"crossref","unstructured":"Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim S (2007) Rosiglitazone for type 2 diabetes mellitus. Cochrane Database Syst Rev (3):CD006063","DOI":"10.1002\/14651858.CD006063.pub2"},{"issue":"8","key":"84_CR122","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","volume":"1771","author":"M Heneka","year":"2007","unstructured":"Heneka M, Landreth G (2007) PPARs in the brain. Biochim Biophys Acta 1771(8):1031\u20131045","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"84_CR123","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncpneuro0586","volume":"3","author":"M Heneka","year":"2007","unstructured":"Heneka M, Landreth G, H\u00fcll M (2007) Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nat Clin Pract Neurol 3(9):496\u2013504","journal-title":"Nat Clin Pract Neurol"},{"issue":"6","key":"84_CR124","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1525-0016(03)00130-8","volume":"7","author":"V Del Gaizo","year":"2003","unstructured":"Del Gaizo V, Payne R (2003) A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7(6):720\u2013730","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"84_CR125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2003.08.017","volume":"80","author":"V Del Gaizo","year":"2003","unstructured":"Del Gaizo V, MacKenzie J, Payne R (2003) Targeting proteins to mitochondria using TAT. Mol Genet Metab 80(1\u20132):170\u2013180","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"84_CR126","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2003.08.017","volume":"80","author":"V Del Gaizo","year":"2003","unstructured":"Marmolino D, Acquaviva F, Pinelli M, Monticelli A, Castaldo I, Filla A, Cocozza S (2008) PPAR-gamma agonist azelaoyl PAF increases frataxin protein and mRNA expression. New implications for the Friedreich\u2019s ataxia theraphy. Cerebellum. Dec. 23 (PMID: 19104905)","journal-title":"Mol Genet Metab"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-008-0084-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-008-0084-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-008-0084-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:53:50Z","timestamp":1559462030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-008-0084-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,23]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s12311-008-0084-2","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,23]]}}}